In this webinar , you’ll learn when and how to select the right analogs to set the most accurate expectations and payer strategy at launch. For example:
- What are the metrics that payers use to evaluate newly launched drugs?
- Using those metrics, how can manufacturers select an ideal analog from the vast historical launch data that Analytics + PAR provides, to most closely and accurately predict payers’ anticipated adoption of a new drug?
- How can users overlay New to Market policies over analog data to precisely segment slow restrictive payers from fast non-restrictive payers at launch?